Skip to main content
Vivanza Biosciences Limited (BOM:530057)
India flag India · Delayed Price · Currency is INR
2.020
+0.090 (4.66%)
At close: Mar 10, 2026

Vivanza Biosciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Net Income
--6.745.475.983.330.75
Upgrade
Depreciation & Amortization
-0.140.120.030.070.1
Upgrade
Other Operating Activities
-3.534.124.194.054.67
Upgrade
Change in Accounts Receivable
-34.89.4-46.39-15.92.88
Upgrade
Change in Inventory
--2.574.68-0.47-17.753.13
Upgrade
Change in Accounts Payable
--56.17-13.1540.6416.2-42.78
Upgrade
Change in Other Net Operating Assets
-2.029.79-13.4434.663.59
Upgrade
Operating Cash Flow
--24.9920.44-9.4624.67-27.64
Upgrade
Capital Expenditures
--0.08-0.38---0.21
Upgrade
Investing Cash Flow
--0.08-0.38---0.21
Upgrade
Short-Term Debt Issued
-----1.82
Upgrade
Long-Term Debt Issued
-28.3-36.53--
Upgrade
Total Debt Issued
-28.3-36.53-1.82
Upgrade
Long-Term Debt Repaid
---40.77--6.04-2.13
Upgrade
Total Debt Repaid
---40.77--6.04-2.13
Upgrade
Net Debt Issued (Repaid)
-28.3-40.7736.53-6.04-0.3
Upgrade
Other Financing Activities
--3.7320.96-26.21-18.7325
Upgrade
Financing Cash Flow
-24.57-19.810.32-24.7724.7
Upgrade
Miscellaneous Cash Flow Adjustments
--0---0
Upgrade
Net Cash Flow
--0.50.260.86-0.1-3.16
Upgrade
Free Cash Flow
--25.0720.06-9.4624.67-27.86
Upgrade
Free Cash Flow Margin
--33.55%7.19%-5.21%22.03%-28.02%
Upgrade
Free Cash Flow Per Share
--0.630.51-0.240.62-0.70
Upgrade
Cash Interest Paid
-3.514.134.194.064.68
Upgrade
Cash Income Tax Paid
-0.071.491.180.010.48
Upgrade
Levered Free Cash Flow
--29.5335.53-27.11-23.72-2.76
Upgrade
Unlevered Free Cash Flow
--27.3438.11-24.49-21.190.16
Upgrade
Change in Working Capital
--21.9210.73-19.6517.22-33.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.